Related Experiment Video
Updated: Oct 7, 2025
Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
Published on: January 26, 2024
Nodal Langerhans cell neoplasm: detailing the diagnostic quandaries
Zachariah Chowdhury1, Juhi Varshney1, Anil Singh2
1Mahamana Pandit Madanmohan Malaviya Cancer Centre & Homi Bhaba Cancer Hospital, Department of Pathology, Varanasi, Uttar Pradesh, India.
Insights
Langerhans cell sarcoma (LCS) is a rare cancer. This case highlights diagnostic challenges in differentiating LCS from lymphoma and emphasizes meticulous pathology for accurate diagnosis.
Area of Science:
- Immunology
- Oncology
- Pathology
Background:
- Langerhans cells (LC) are crucial antigen-presenting cells in the immune system.
- Tumors of LC include Langerhans cell histiocytosis (LCH) and the rarer Langerhans cell sarcoma (LCS).
- LCS, particularly nodal presentation, is aggressive and difficult to diagnose.
Observation:
- A 29-year-old male presented with generalized lymphadenopathy, initially suspected as lymphoma.
- Initial histomorphological and immunohistochemical evaluations were inconclusive, presenting diagnostic challenges.
- Positron emission tomography (PET) scans and extensive immunohistochemistry were vital for diagnosis.
Findings:
- The case involved a rare nodal presentation of Langerhans cell sarcoma.
- Accurate diagnosis required integrating cytopathology, histomorphology, immunohistochemistry, and clinical findings.
- The final diagnosis was Langerhans cell histiocytosis progressing to Langerhans cell sarcoma.
Implications:
- This case underscores the diagnostic complexities and "grey zone" areas in Langerhans cell neoplasms.
- Meticulous pathological analysis and ancillary studies are indispensable for definitive diagnosis.
- Improved diagnostic strategies are crucial for managing aggressive LCS and improving patient outcomes.
Abstract:
Langerhans cells, found in the supra-basal region of the mucous membranes in the epidermis of the skin, in lymph nodes and thymus, function as antigen-presenting cells within the histiocyte system. Tumors derived from Langerhans cells (LC) can be divided according to the degree of cytological atypia and clinical behavior into Langerhans cell histiocytosis (LCH) and Langerhans cell sarcoma (LCS). LCS is rare, and the nodal presentation is even rarer with challenging histological characteristics. LCS has a dismal overcome despite intensive chemotherapy. Herein, we report a case of a 29-year-old male who presented with generalized lymphadenopathy initially considered as a lymphoma. An outright definitive diagnosis could not be attained in the initial histomorphological and immunohistochemical evaluation, fraught with differential diagnoses. The key to decoding the precise neoplasm was a combination of the cytopathologic features, review of the histomorphology, and extensive immunohistochemical assessment in conjunction with the clinical and positron emission tomography (PET) scan findings. The best diagnosis proffered was a Langerhans cell histiocytosis progressing to Langerhans cell sarcoma. This case highlights the grey zone areas in LC neoplasms, the diagnostic conundrums encountered, the indispensable role of meticulous pathological analysis, and the importance of ancillary studies in hammering out the final diagnosis.
